The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Rapid Disease Tests Market Research Report 2025
Synopsis
Rapid tests are often referred to as point-of-care tests because rather than sending a blood sample to a laboratory, the test can be conducted and the result read in a doctor’s office or a community setting, without specialised laboratory equipment. The sample taken is usually either finger-prick blood or saliva.
The global Rapid Disease Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rapid Disease Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Disease Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rapid Disease Tests in Infectious Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rapid Disease Tests include Becton, Dickinson and Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Akers Biosciences, Inc., Abbott, Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc. and OraSure Technologies, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rapid Disease Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Disease Tests.
Report Scope
The Rapid Disease Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Disease Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Disease Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton, Dickinson and Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Akers Biosciences, Inc.
Abbott
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
Creative Diagnostics
Cardinal Health
RayBiotech
Guangzhou Wondfo Biotech
Sinocare
Maccura Biotechnology Co
Segment by Type
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
Segment by Application
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rapid Disease Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Rapid tests are often referred to as point-of-care tests because rather than sending a blood sample to a laboratory, the test can be conducted and the result read in a doctor’s office or a community setting, without specialised laboratory equipment. The sample taken is usually either finger-prick blood or saliva.
The global Rapid Disease Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rapid Disease Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rapid Disease Tests is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Rapid Disease Tests in Infectious Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Rapid Disease Tests include Becton, Dickinson and Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Akers Biosciences, Inc., Abbott, Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc. and OraSure Technologies, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rapid Disease Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Disease Tests.
Report Scope
The Rapid Disease Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rapid Disease Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Disease Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton, Dickinson and Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Akers Biosciences, Inc.
Abbott
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
Creative Diagnostics
Cardinal Health
RayBiotech
Guangzhou Wondfo Biotech
Sinocare
Maccura Biotechnology Co
Segment by Type
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product
Segment by Application
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rapid Disease Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Disease Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Over-the-counter (OTC) Rapid Test Product
1.2.3 Professional Rapid Test Product
1.3 Market by Application
1.3.1 Global Rapid Disease Tests Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Cardiology
1.3.4 Oncology
1.3.5 Pregnancy and Fertility
1.3.6 Toxicology
1.3.7 Glucose Monitoring
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rapid Disease Tests Market Perspective (2019-2030)
2.2 Rapid Disease Tests Growth Trends by Region
2.2.1 Global Rapid Disease Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Rapid Disease Tests Historic Market Size by Region (2019-2024)
2.2.3 Rapid Disease Tests Forecasted Market Size by Region (2025-2030)
2.3 Rapid Disease Tests Market Dynamics
2.3.1 Rapid Disease Tests Industry Trends
2.3.2 Rapid Disease Tests Market Drivers
2.3.3 Rapid Disease Tests Market Challenges
2.3.4 Rapid Disease Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rapid Disease Tests Players by Revenue
3.1.1 Global Top Rapid Disease Tests Players by Revenue (2019-2024)
3.1.2 Global Rapid Disease Tests Revenue Market Share by Players (2019-2024)
3.2 Global Rapid Disease Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rapid Disease Tests Revenue
3.4 Global Rapid Disease Tests Market Concentration Ratio
3.4.1 Global Rapid Disease Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Disease Tests Revenue in 2023
3.5 Rapid Disease Tests Key Players Head office and Area Served
3.6 Key Players Rapid Disease Tests Product Solution and Service
3.7 Date of Enter into Rapid Disease Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rapid Disease Tests Breakdown Data by Type
4.1 Global Rapid Disease Tests Historic Market Size by Type (2019-2024)
4.2 Global Rapid Disease Tests Forecasted Market Size by Type (2025-2030)
5 Rapid Disease Tests Breakdown Data by Application
5.1 Global Rapid Disease Tests Historic Market Size by Application (2019-2024)
5.2 Global Rapid Disease Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Rapid Disease Tests Market Size (2019-2030)
6.2 North America Rapid Disease Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Rapid Disease Tests Market Size by Country (2019-2024)
6.4 North America Rapid Disease Tests Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rapid Disease Tests Market Size (2019-2030)
7.2 Europe Rapid Disease Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Rapid Disease Tests Market Size by Country (2019-2024)
7.4 Europe Rapid Disease Tests Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rapid Disease Tests Market Size (2019-2030)
8.2 Asia-Pacific Rapid Disease Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Rapid Disease Tests Market Size by Region (2019-2024)
8.4 Asia-Pacific Rapid Disease Tests Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rapid Disease Tests Market Size (2019-2030)
9.2 Latin America Rapid Disease Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Rapid Disease Tests Market Size by Country (2019-2024)
9.4 Latin America Rapid Disease Tests Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rapid Disease Tests Market Size (2019-2030)
10.2 Middle East & Africa Rapid Disease Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Rapid Disease Tests Market Size by Country (2019-2024)
10.4 Middle East & Africa Rapid Disease Tests Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton, Dickinson and Company
11.1.1 Becton, Dickinson and Company Company Detail
11.1.2 Becton, Dickinson and Company Business Overview
11.1.3 Becton, Dickinson and Company Rapid Disease Tests Introduction
11.1.4 Becton, Dickinson and Company Revenue in Rapid Disease Tests Business (2019-2024)
11.1.5 Becton, Dickinson and Company Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Rapid Disease Tests Introduction
11.2.4 Bio-Rad Laboratories Revenue in Rapid Disease Tests Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Rapid Disease Tests Introduction
11.3.4 Thermo Fisher Scientific Revenue in Rapid Disease Tests Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Akers Biosciences, Inc.
11.4.1 Akers Biosciences, Inc. Company Detail
11.4.2 Akers Biosciences, Inc. Business Overview
11.4.3 Akers Biosciences, Inc. Rapid Disease Tests Introduction
11.4.4 Akers Biosciences, Inc. Revenue in Rapid Disease Tests Business (2019-2024)
11.4.5 Akers Biosciences, Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Rapid Disease Tests Introduction
11.5.4 Abbott Revenue in Rapid Disease Tests Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Cepheid, Inc.
11.6.1 Cepheid, Inc. Company Detail
11.6.2 Cepheid, Inc. Business Overview
11.6.3 Cepheid, Inc. Rapid Disease Tests Introduction
11.6.4 Cepheid, Inc. Revenue in Rapid Disease Tests Business (2019-2024)
11.6.5 Cepheid, Inc. Recent Development
11.7 Hologic, Inc.
11.7.1 Hologic, Inc. Company Detail
11.7.2 Hologic, Inc. Business Overview
11.7.3 Hologic, Inc. Rapid Disease Tests Introduction
11.7.4 Hologic, Inc. Revenue in Rapid Disease Tests Business (2019-2024)
11.7.5 Hologic, Inc. Recent Development
11.8 Meridian Bioscience, Inc.
11.8.1 Meridian Bioscience, Inc. Company Detail
11.8.2 Meridian Bioscience, Inc. Business Overview
11.8.3 Meridian Bioscience, Inc. Rapid Disease Tests Introduction
11.8.4 Meridian Bioscience, Inc. Revenue in Rapid Disease Tests Business (2019-2024)
11.8.5 Meridian Bioscience, Inc. Recent Development
11.9 OraSure Technologies, Inc.
11.9.1 OraSure Technologies, Inc. Company Detail
11.9.2 OraSure Technologies, Inc. Business Overview
11.9.3 OraSure Technologies, Inc. Rapid Disease Tests Introduction
11.9.4 OraSure Technologies, Inc. Revenue in Rapid Disease Tests Business (2019-2024)
11.9.5 OraSure Technologies, Inc. Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Detail
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Rapid Disease Tests Introduction
11.10.4 Quidel Corporation Revenue in Rapid Disease Tests Business (2019-2024)
11.10.5 Quidel Corporation Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Detail
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics Rapid Disease Tests Introduction
11.11.4 Roche Diagnostics Revenue in Rapid Disease Tests Business (2019-2024)
11.11.5 Roche Diagnostics Recent Development
11.12 Creative Diagnostics
11.12.1 Creative Diagnostics Company Detail
11.12.2 Creative Diagnostics Business Overview
11.12.3 Creative Diagnostics Rapid Disease Tests Introduction
11.12.4 Creative Diagnostics Revenue in Rapid Disease Tests Business (2019-2024)
11.12.5 Creative Diagnostics Recent Development
11.13 Cardinal Health
11.13.1 Cardinal Health Company Detail
11.13.2 Cardinal Health Business Overview
11.13.3 Cardinal Health Rapid Disease Tests Introduction
11.13.4 Cardinal Health Revenue in Rapid Disease Tests Business (2019-2024)
11.13.5 Cardinal Health Recent Development
11.14 RayBiotech
11.14.1 RayBiotech Company Detail
11.14.2 RayBiotech Business Overview
11.14.3 RayBiotech Rapid Disease Tests Introduction
11.14.4 RayBiotech Revenue in Rapid Disease Tests Business (2019-2024)
11.14.5 RayBiotech Recent Development
11.15 Guangzhou Wondfo Biotech
11.15.1 Guangzhou Wondfo Biotech Company Detail
11.15.2 Guangzhou Wondfo Biotech Business Overview
11.15.3 Guangzhou Wondfo Biotech Rapid Disease Tests Introduction
11.15.4 Guangzhou Wondfo Biotech Revenue in Rapid Disease Tests Business (2019-2024)
11.15.5 Guangzhou Wondfo Biotech Recent Development
11.16 Sinocare
11.16.1 Sinocare Company Detail
11.16.2 Sinocare Business Overview
11.16.3 Sinocare Rapid Disease Tests Introduction
11.16.4 Sinocare Revenue in Rapid Disease Tests Business (2019-2024)
11.16.5 Sinocare Recent Development
11.17 Maccura Biotechnology Co
11.17.1 Maccura Biotechnology Co Company Detail
11.17.2 Maccura Biotechnology Co Business Overview
11.17.3 Maccura Biotechnology Co Rapid Disease Tests Introduction
11.17.4 Maccura Biotechnology Co Revenue in Rapid Disease Tests Business (2019-2024)
11.17.5 Maccura Biotechnology Co Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Rapid Disease Tests Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Over-the-counter (OTC) Rapid Test Product
Table 3. Key Players of Professional Rapid Test Product
Table 4. Global Rapid Disease Tests Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Rapid Disease Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Rapid Disease Tests Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Rapid Disease Tests Market Share by Region (2019-2024)
Table 8. Global Rapid Disease Tests Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Rapid Disease Tests Market Share by Region (2025-2030)
Table 10. Rapid Disease Tests Market Trends
Table 11. Rapid Disease Tests Market Drivers
Table 12. Rapid Disease Tests Market Challenges
Table 13. Rapid Disease Tests Market Restraints
Table 14. Global Rapid Disease Tests Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Rapid Disease Tests Market Share by Players (2019-2024)
Table 16. Global Top Rapid Disease Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Disease Tests as of 2023)
Table 17. Ranking of Global Top Rapid Disease Tests Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Rapid Disease Tests Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Rapid Disease Tests Product Solution and Service
Table 21. Date of Enter into Rapid Disease Tests Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Rapid Disease Tests Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Rapid Disease Tests Revenue Market Share by Type (2019-2024)
Table 25. Global Rapid Disease Tests Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Rapid Disease Tests Revenue Market Share by Type (2025-2030)
Table 27. Global Rapid Disease Tests Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Rapid Disease Tests Revenue Market Share by Application (2019-2024)
Table 29. Global Rapid Disease Tests Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Rapid Disease Tests Revenue Market Share by Application (2025-2030)
Table 31. North America Rapid Disease Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Rapid Disease Tests Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Rapid Disease Tests Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Rapid Disease Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Rapid Disease Tests Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Rapid Disease Tests Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Rapid Disease Tests Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Rapid Disease Tests Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Rapid Disease Tests Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rapid Disease Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Rapid Disease Tests Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Rapid Disease Tests Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Rapid Disease Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Rapid Disease Tests Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Rapid Disease Tests Market Size by Country (2025-2030) & (US$ Million)
Table 46. Becton, Dickinson and Company Company Detail
Table 47. Becton, Dickinson and Company Business Overview
Table 48. Becton, Dickinson and Company Rapid Disease Tests Product
Table 49. Becton, Dickinson and Company Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 50. Becton, Dickinson and Company Recent Development
Table 51. Bio-Rad Laboratories Company Detail
Table 52. Bio-Rad Laboratories Business Overview
Table 53. Bio-Rad Laboratories Rapid Disease Tests Product
Table 54. Bio-Rad Laboratories Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 55. Bio-Rad Laboratories Recent Development
Table 56. Thermo Fisher Scientific Company Detail
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Rapid Disease Tests Product
Table 59. Thermo Fisher Scientific Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Akers Biosciences, Inc. Company Detail
Table 62. Akers Biosciences, Inc. Business Overview
Table 63. Akers Biosciences, Inc. Rapid Disease Tests Product
Table 64. Akers Biosciences, Inc. Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 65. Akers Biosciences, Inc. Recent Development
Table 66. Abbott Company Detail
Table 67. Abbott Business Overview
Table 68. Abbott Rapid Disease Tests Product
Table 69. Abbott Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Cepheid, Inc. Company Detail
Table 72. Cepheid, Inc. Business Overview
Table 73. Cepheid, Inc. Rapid Disease Tests Product
Table 74. Cepheid, Inc. Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 75. Cepheid, Inc. Recent Development
Table 76. Hologic, Inc. Company Detail
Table 77. Hologic, Inc. Business Overview
Table 78. Hologic, Inc. Rapid Disease Tests Product
Table 79. Hologic, Inc. Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 80. Hologic, Inc. Recent Development
Table 81. Meridian Bioscience, Inc. Company Detail
Table 82. Meridian Bioscience, Inc. Business Overview
Table 83. Meridian Bioscience, Inc. Rapid Disease Tests Product
Table 84. Meridian Bioscience, Inc. Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 85. Meridian Bioscience, Inc. Recent Development
Table 86. OraSure Technologies, Inc. Company Detail
Table 87. OraSure Technologies, Inc. Business Overview
Table 88. OraSure Technologies, Inc. Rapid Disease Tests Product
Table 89. OraSure Technologies, Inc. Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 90. OraSure Technologies, Inc. Recent Development
Table 91. Quidel Corporation Company Detail
Table 92. Quidel Corporation Business Overview
Table 93. Quidel Corporation Rapid Disease Tests Product
Table 94. Quidel Corporation Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 95. Quidel Corporation Recent Development
Table 96. Roche Diagnostics Company Detail
Table 97. Roche Diagnostics Business Overview
Table 98. Roche Diagnostics Rapid Disease Tests Product
Table 99. Roche Diagnostics Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 100. Roche Diagnostics Recent Development
Table 101. Creative Diagnostics Company Detail
Table 102. Creative Diagnostics Business Overview
Table 103. Creative Diagnostics Rapid Disease Tests Product
Table 104. Creative Diagnostics Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 105. Creative Diagnostics Recent Development
Table 106. Cardinal Health Company Detail
Table 107. Cardinal Health Business Overview
Table 108. Cardinal Health Rapid Disease Tests Product
Table 109. Cardinal Health Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 110. Cardinal Health Recent Development
Table 111. RayBiotech Company Detail
Table 112. RayBiotech Business Overview
Table 113. RayBiotech Rapid Disease Tests Product
Table 114. RayBiotech Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 115. RayBiotech Recent Development
Table 116. Guangzhou Wondfo Biotech Company Detail
Table 117. Guangzhou Wondfo Biotech Business Overview
Table 118. Guangzhou Wondfo Biotech Rapid Disease Tests Product
Table 119. Guangzhou Wondfo Biotech Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 120. Guangzhou Wondfo Biotech Recent Development
Table 121. Sinocare Company Detail
Table 122. Sinocare Business Overview
Table 123. Sinocare Rapid Disease Tests Product
Table 124. Sinocare Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 125. Sinocare Recent Development
Table 126. Maccura Biotechnology Co Company Detail
Table 127. Maccura Biotechnology Co Business Overview
Table 128. Maccura Biotechnology Co Rapid Disease Tests Product
Table 129. Maccura Biotechnology Co Revenue in Rapid Disease Tests Business (2019-2024) & (US$ Million)
Table 130. Maccura Biotechnology Co Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rapid Disease Tests Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Rapid Disease Tests Market Share by Type: 2023 VS 2030
Figure 3. Over-the-counter (OTC) Rapid Test Product Features
Figure 4. Professional Rapid Test Product Features
Figure 5. Global Rapid Disease Tests Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Rapid Disease Tests Market Share by Application: 2023 VS 2030
Figure 7. Infectious Disease Case Studies
Figure 8. Cardiology Case Studies
Figure 9. Oncology Case Studies
Figure 10. Pregnancy and Fertility Case Studies
Figure 11. Toxicology Case Studies
Figure 12. Glucose Monitoring Case Studies
Figure 13. Others Case Studies
Figure 14. Rapid Disease Tests Report Years Considered
Figure 15. Global Rapid Disease Tests Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Rapid Disease Tests Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Rapid Disease Tests Market Share by Region: 2023 VS 2030
Figure 18. Global Rapid Disease Tests Market Share by Players in 2023
Figure 19. Global Top Rapid Disease Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Disease Tests as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Rapid Disease Tests Revenue in 2023
Figure 21. North America Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Rapid Disease Tests Market Share by Country (2019-2030)
Figure 23. United States Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Rapid Disease Tests Market Share by Country (2019-2030)
Figure 27. Germany Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Rapid Disease Tests Market Share by Region (2019-2030)
Figure 35. China Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Rapid Disease Tests Market Share by Country (2019-2030)
Figure 43. Mexico Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Rapid Disease Tests Market Share by Country (2019-2030)
Figure 47. Turkey Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Rapid Disease Tests Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Becton, Dickinson and Company Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 52. Akers Biosciences, Inc. Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 53. Abbott Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 54. Cepheid, Inc. Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 55. Hologic, Inc. Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 56. Meridian Bioscience, Inc. Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 57. OraSure Technologies, Inc. Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 58. Quidel Corporation Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 59. Roche Diagnostics Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 60. Creative Diagnostics Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 61. Cardinal Health Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 62. RayBiotech Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 63. Guangzhou Wondfo Biotech Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 64. Sinocare Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 65. Maccura Biotechnology Co Revenue Growth Rate in Rapid Disease Tests Business (2019-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
